Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Patrick D. Yeramian currently holds 205,605 shares of Amylyx Pharmaceuticals, Inc. (AMLX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Patrick D. Yeramian has been a net seller of AMLX stock. They have purchased $0 and sold $5.5M worth of shares.
Patrick D. Yeramian's most recent insider trade was on Jan 9, 2024, when they sold 2,812 shares at $16.33 per share.
Patrick D. Yeramian serves as Executive at Amylyx Pharmaceuticals, Inc. (AMLX). They have executed 20 insider transactions totaling $5.5M over their tenure at the company.
Patrick D. Yeramian holds the position of Executive at Amylyx Pharmaceuticals, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 4 years and currently hold a stake valued at $0.
Patrick D. Yeramian has shown a selling trading pattern, with $0 in total purchases and $5.5M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Patrick D. Yeramian was on Mar 16, 2023, when they sold $1.7M worth of AMLX shares. This transaction involved 52,211 shares at $31.85 per share.
Patrick D. Yeramian currently owns 205,605 shares of Amylyx Pharmaceuticals, Inc. (AMLX), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Patrick D. Yeramian's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Patrick D. Yeramian has 20 Form 4 filings on record as an insider at Amylyx Pharmaceuticals, Inc..
Set alerts for Patrick D. Yeramian and 40,000+ other insiders.